Oncogenic KRAS mediates resistance to MET targeted therapy in non-small cell lung cancer (NSCLC) with MET mutations that induce exon14 skipping Meeting Abstract

  

Authors:	Suzawa, K.; Offin, M. D.; Kurzatkowski, C.; Liu, D.; Vojnic, M.; Smith, R. S.; Mattar, M.; Khodos, I.; de Stanchina, E.; Sabari, J. K.; Lockwood, W. W.; Drilon, A. E.; Ladanyi, M.; Somwar, R.
Abstract Title:	Oncogenic KRAS mediates resistance to MET targeted therapy in non-small cell lung cancer (NSCLC) with MET mutations that induce exon14 skipping
Meeting Title:	109th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title:	Cancer Research
Volume:	78
Issue:	13 Suppl.
Meeting Dates:	2018 Apr 14-18
Meeting Location:	Chicago, IL
ISSN:	0008-5472
Publisher:	American Association for Cancer Research
Date Published:	2018-07-01
Language:	English
ACCESSION:	WOS:000468818904217
DOI:	10.1158/1538-7445.Am2018-1826
PROVIDER:	wos
Notes:	Meeting Abstract: 1826 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/148156